Show simple item record

Rapid early progression (Rep) of glioblastoma is an independent negative prognostic factor: results from a systematic review and meta-analysis

dc.contributor.authorWaqar, M.
dc.contributor.authorRoncaroli, F.
dc.contributor.authorLehrer, E.
dc.contributor.authorPalmer, J.
dc.contributor.authorVillanueva-Meyer, J.
dc.contributor.authorBraunstein, S.
dc.contributor.authorHall, E.
dc.contributor.authorAznar, Marianne Camille
dc.contributor.authorHamer, P. D. W.
dc.contributor.authorD'Urso, P.
dc.contributor.authorTrifiletti, D.
dc.contributor.authorQuinones-Hinojosa, A.
dc.contributor.authorWesseling, P.
dc.contributor.authorBorst, Gerben R
dc.date.accessioned2023-01-24T10:32:29Z
dc.date.available2023-01-24T10:32:29Z
dc.date.issued2022en
dc.identifier.citationWaqar M, Roncaroli F, Lehrer E, Palmer J, Villanueva-Meyer J, Braunstein S, et al. Rapid Early Progression (Rep) of Glioblastoma Is an Independent Negative Prognostic Factor: Results from a Systematic Review and Meta-Analysis. Neuro-oncology. 2022 Nov;24:172-. PubMed PMID: WOS:000888571000662.en
dc.identifier.doi10.1093/noajnl/vdac075en
dc.identifier.urihttp://hdl.handle.net/10541/625992
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1093/noajnl/vdac075en
dc.titleRapid early progression (Rep) of glioblastoma is an independent negative prognostic factor: results from a systematic review and meta-analysisen
dc.typeMeetings and Proceedingsen
dc.contributor.departmentDepartment of Neurosurgery, Geoffrey Jefferson Brain Research Centre, Salford Royal NHS Foundation Trust, Manchesteren
dc.identifier.journalNeuro-Oncologyen
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record